JPH11222440A5 - - Google Patents

Info

Publication number
JPH11222440A5
JPH11222440A5 JP1998021809A JP2180998A JPH11222440A5 JP H11222440 A5 JPH11222440 A5 JP H11222440A5 JP 1998021809 A JP1998021809 A JP 1998021809A JP 2180998 A JP2180998 A JP 2180998A JP H11222440 A5 JPH11222440 A5 JP H11222440A5
Authority
JP
Japan
Prior art keywords
pth
leukopenia
cells
administration
bone marrow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998021809A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11222440A (ja
JP4414494B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP02180998A priority Critical patent/JP4414494B2/ja
Priority claimed from JP02180998A external-priority patent/JP4414494B2/ja
Publication of JPH11222440A publication Critical patent/JPH11222440A/ja
Publication of JPH11222440A5 publication Critical patent/JPH11222440A5/ja
Application granted granted Critical
Publication of JP4414494B2 publication Critical patent/JP4414494B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP02180998A 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤 Expired - Fee Related JP4414494B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP02180998A JP4414494B2 (ja) 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP02180998A JP4414494B2 (ja) 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤

Publications (3)

Publication Number Publication Date
JPH11222440A JPH11222440A (ja) 1999-08-17
JPH11222440A5 true JPH11222440A5 (enExample) 2005-07-07
JP4414494B2 JP4414494B2 (ja) 2010-02-10

Family

ID=12065393

Family Applications (1)

Application Number Title Priority Date Filing Date
JP02180998A Expired - Fee Related JP4414494B2 (ja) 1998-02-03 1998-02-03 白血球減少症の予防剤および治療剤

Country Status (1)

Country Link
JP (1) JP4414494B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129164A (en) 1996-09-26 2007-05-15 Chugai Pharmaceutical Co Ltd An antibody against peptides associated with human parathyroid hormone
DE69837707T2 (de) 1997-05-15 2008-01-10 Chugai Seiyaku K.K. Heilmittel für kachexie
CA2373885A1 (en) * 1999-07-02 2001-01-11 Chugai Seiyaku Kabushiki Kaisha Therapeutic agent for diseases caused by pth or pthrp
TWI255718B (en) 1999-07-02 2006-06-01 Chugai Pharmaceutical Co Ltd Ameliorative agent for low vasopressin concentration
EP1987842A1 (en) 2000-04-28 2008-11-05 Chugai Seiyaku Kabushiki Kaisha Cell proliferation inhibitor

Similar Documents

Publication Publication Date Title
RU2128056C1 (ru) Способы и препараты для лечения заболеваний интерфероном, характеризующиеся сниженными побочными эффектами
JP2914393B2 (ja) ヒトサイトカイン、インターロイキン―9
ES2380009T3 (es) Métodos para movilizar las células madre/progenitoras
JP4416839B2 (ja) 二次性免疫不全症の治療法
US6719969B1 (en) Treatment of liver disease and injury with CXC chemokines
JPH10510147A (ja) 二次性免疫不全症の治療用薬剤の製造方法
JP4057648B2 (ja) 造血前駆細胞の増殖を促進するチオール類
RU2351357C2 (ru) Фармацевтическая композиция, используемая для мобилизации стволовых клеток
US5104653A (en) Use of human interferon-beta for stimulation of erythropoiesis
JP3496937B2 (ja) コンセンサスヒトインターフェロンを含有する細胞増殖障害治療用の医用組成物
AU664210B2 (en) Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
JPH04506818A (ja) 造血細胞の成熟
JPH11222440A5 (enExample)
JP4414494B2 (ja) 白血球減少症の予防剤および治療剤
JPH11512747A (ja) 造血幹細胞の動員方法
Gabrilove et al. Granulocyte colony-stimulating factor: preclinical and clinical studies
Parker et al. Inhibitors of haemopoiesis and their potential clinical relevance
US20030099637A1 (en) Remedies for interstitial pneumonia , method of constructing animal model of this disease, and screening method with the use of the same
WO2004016258A1 (en) Therapeutical use of guanylhydrazones for treating diseases associated with dendritic cell maturation
JP2002510641A (ja) 神経退化疾患治療用短ペプチド
WO2001010899A2 (en) Treatment of liver disease and injury with cxc chemokines
Hoyos-Bachiloglu et al. Precision medicine as treatment for primary immunodeficiency and immune dysregulation
JPWO1993011769A1 (ja) 制癌剤
JP2007505128A (ja) 造血を高める方法
WO2006132236A1 (ja) 白血球及び/又は造血幹・前駆細胞動員剤